Ariyaratnam Roshan, Palmqvist Charlotta L, Hider Phil, Laing Grant L, Stupart Douglas, Wilson Leona, Clarke Damian L, Hagander Lars, Watters David A, Gruen Russell L
Monash University & Barwon Health, Melbourne, Australia.
Department of Clinical Sciences in Lund, Paediatric Surgery and Global Paediatrics, Faculty of Medicine, Lund University, Children's Hospital, Lund, Sweden.
Surgery. 2015 Jul;158(1):17-26. doi: 10.1016/j.surg.2015.03.024. Epub 2015 May 6.
The proportion of patients who die during or after surgery, otherwise known as the perioperative mortality rate (POMR), is a credible indicator of the safety and quality of operative care. Its accuracy and usefulness as a metric, however, particularly one that enables valid comparisons over time or between jurisdictions, has been limited by lack of a standardized approach to measurement and calculation, poor understanding of when in relation to surgery it is best measured, and whether risk-adjustment is needed. Our aim was to evaluate the value of POMR as a global surgery metric by addressing these issues using 4, large, mixed, surgical datasets that represent high-, middle-, and low-income countries.
We obtained data from the New Zealand National Minimum Dataset, the Geelong Hospital patient management system in Australia, and purpose-built surgical databases in Pietermaritzburg, South Africa, and Port Moresby, Papua New Guinea. For each site, we calculated the POMR overall as well as for nonemergency and emergency admissions. We assessed the effect of admission episodes and procedures as the denominator and the difference between in-hospital POMR and POMR, including postdischarge deaths up to 30 days. To determine the need for risk-adjustment for age and admission urgency, we used univariate and multivariate logistic regression to assess the effect on relative POMR for each site.
A total of 1,362,635 patient admissions involving 1,514,242 procedures were included. More than 60% of admissions in Pietermaritzburg and Port Moresby were emergencies, compared with less than 30% in New Zealand and Geelong. Also, Pietermaritzburg and Port Moresby had much younger patient populations (P < .001). A total of 8,655 deaths were recorded within 30 days, and 8-20% of in-hospital deaths occurred on the same day as the first operation. In-hospital POMR ranged approximately 9-fold, from 0.38 per 100 admissions in New Zealand to 3.44 per 100 admissions in Pietermaritzburg. In New Zealand, in-hospital 30-day POMR underestimated total 30-day POMR by approximately one third. The difference in POMR if procedures were used instead of admission episodes ranged from 7 to 70%, although this difference was less when central line and pacemaker insertions were excluded. Age older than 65 years and emergency admission had large, independent effects on POMR but relatively little effect in multivariate analysis on the relative odds of in-hospital death at each site.
It is possible to collect POMR in countries at all level of development. Although age and admission urgency are strong, independent associations with POMR, a substantial amount of its variance is site-specific and may reflect the safety of operative and anesthetic facilities and processes. Risk-adjustment is desirable but not essential for monitoring system performance. POMR varies depending on the choice of denominator, and in-hospital deaths appear to underestimate 30-day mortality by up to one third. Standardized approaches to reporting and analysis will strengthen the validity of POMR as the principal indicator of the safety of surgery and anesthesia care.
在手术期间或手术后死亡的患者比例,即围手术期死亡率(POMR),是手术护理安全性和质量的可靠指标。然而,作为一种衡量标准,其准确性和实用性,尤其是作为一种能够在不同时间或不同司法管辖区进行有效比较的指标,受到测量和计算方法缺乏标准化、对何时进行最佳测量以及是否需要风险调整理解不足的限制。我们的目的是通过使用代表高、中、低收入国家的4个大型混合手术数据集来解决这些问题,从而评估POMR作为全球手术指标的价值。
我们从新西兰国家最低数据集、澳大利亚吉朗医院患者管理系统以及南非彼得马里茨堡和巴布亚新几内亚莫尔斯比港专门构建的手术数据库中获取数据。对于每个地点,我们计算了总体POMR以及非急诊和急诊入院的POMR。我们评估了以入院次数和手术作为分母的影响,以及住院POMR与POMR之间的差异,包括出院后30天内的死亡情况。为了确定年龄和入院紧急程度的风险调整需求,我们使用单变量和多变量逻辑回归来评估对每个地点相对POMR的影响。
共纳入1362635例患者入院,涉及1514242例手术。彼得马里茨堡和莫尔斯比港超过60%的入院是急诊,而新西兰和吉朗不到30%。此外,彼得马里茨堡和莫尔斯比港的患者群体更年轻(P <.001)。共记录了30天内8655例死亡,8 - 20%的住院死亡发生在首次手术当天。住院POMR范围约为9倍,从新西兰每100例入院0.38例到彼得马里茨堡每100例入院3.44例。在新西兰,住院30天POMR比总30天POMR低估了约三分之一。如果以手术而非入院次数作为分母,POMR的差异范围为7%至70%,不过排除中心静脉置管和起搏器植入时这种差异较小。65岁以上年龄和急诊入院对POMR有较大的独立影响,但在多变量分析中对每个地点住院死亡的相对几率影响相对较小。
在所有发展水平的国家都有可能收集POMR。虽然年龄和入院紧急程度与POMR有强烈的独立关联,但其大量变异是特定地点的,可能反映了手术和麻醉设施及流程的安全性。风险调整对于监测系统性能是可取的,但并非必不可少。POMR因分母的选择而异,住院死亡似乎低估了30天死亡率达三分之一。标准化的报告和分析方法将加强POMR作为手术和麻醉护理安全性主要指标的有效性。